Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

579
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
579
Relative Risk01:12

Relative Risk

2.6K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.6K
Actuarial Approach01:20

Actuarial Approach

384
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
384
Equity Theory01:26

Equity Theory

404
Equity theory explains how our sense of fairness influences the dynamics of close relationships. Rooted in social psychology, the theory posits that individuals evaluate fairness by comparing the ratio of their contributions to the rewards they receive. Relationship satisfaction is highest when these ratios are perceived as balanced between partners, promoting mutual reciprocity and a sense of justice.Equity vs. Equality in RelationshipsEquity is distinct from equality. Fairness does not...
404
Hazard Rate01:11

Hazard Rate

520
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
520
Hazard Ratio01:12

Hazard Ratio

737
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
737

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep-Learning Solution Providing Molecular Marker Subtyping of Breast Cancer Whole Slide Images: Protocol for a UK Clinical Service Evaluation Study.

JMIR research protocols·2026
Same author

Protocol for the health economic evaluation of nature-based social prescribing against loneliness alongside the RECETAS trials.

BMC public health·2026
Same author

Indirect Effects in Health Economic Models of Vaccines: Should We Include Them, and How Do We Model Them?

Applied health economics and health policy·2026
Same author

Affordability decision rules: a systematic review and framework for categorising budget impact thresholds across health systems.

The Lancet. Global health·2025
Same author

The Use of EQ-5D in the Middle East and North Africa Region: A Systematic Literature Review.

PharmacoEconomics·2025
Same author

Machine Learning-Assisted Health Economics and Policy Reviews: A Comparative Assessment.

Applied health economics and health policy·2025
Same journal

Coordinating care across hospitals: how integration shapes patient mobility.

The European journal of health economics : HEPAC : health economics in prevention and care·2026
Same journal

A comparative analysis of managed entry agreements in Europe: trends, reporting practices, and financial outcomes.

The European journal of health economics : HEPAC : health economics in prevention and care·2026
Same journal

Comparing universal health coverage models: an analysis of policy transmission efficiency in SAARC and ASEAN countries.

The European journal of health economics : HEPAC : health economics in prevention and care·2026
Same journal

Development and validation of solomon's socioeconomic status index (SESI): a multidimensional household classification tool for South Asia.

The European journal of health economics : HEPAC : health economics in prevention and care·2026
Same journal

Who pays and Who benefits? A distributional health-economic evaluation of strengthening the UK soft drinks industry levy.

The European journal of health economics : HEPAC : health economics in prevention and care·2026
Same journal

Getting fairer over time? Assessing changes in health technology funding processes using the accountability for reasonableness (A4R) framework.

The European journal of health economics : HEPAC : health economics in prevention and care·2026
See all related articles

Related Experiment Video

Updated: Apr 16, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.8K

When do performance-based risk-sharing arrangements make sense?

Michael Drummond1

  • 1Centre for Health Economics, Alcuin A Block, University of York, Heslington, York, YO10 5DD, UK, mike.drummond@york.ac.uk.

The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|March 19, 2015
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.1K

Related Experiment Videos

Last Updated: Apr 16, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.8K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.1K